Published in Blood Weekly, October 17th, 2002
"Preclinical studies have established that implantation of bone marrow-mononuclear cells, including endothelial progenitor cells, into ischaemic limbs increases collateral vessel formation," according to Eriko Tateishi-Yuyama and colleagues at Kansai Medical University in Osaka, the Kurume University School of Medicine in Kurume, and Jichi Medical School in Tochigi.
A pilot clinical study by Tateishi-Yuyama and coauthors showed that such treatment could be safe and effective.
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Blood Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.